Royalty Pharma Agrees to Acquire Royalty Interest in
Olpasiran is an siRNA therapeutic being developed by Amgen to reduce risk of cardiovascular disease Arrowhead retains rights to $400 million in...
Source: globenewswire.com
Page 4 - Sci Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sci Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sci Communications Today - Breaking & Trending Today
Investegate |Providence Therapeutics Announcements | Providence Therapeutics: Providence Therapeutics Appoints Judyanna Yu as Chief Financial Officer
Investegate announcements from Providence Therapeutics, Providence Therapeutics Appoints Judyanna Yu as Chief Financial Officer
Source: investegate.co.uk
Providence Therapeutics Appoints Judyanna Yu as Chief Financial Officer
CALGARY, Alberta, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Providence Therapeutics Holdings Inc. ("Providence"), a biopharmaceutical company developing messenger RNA (mRNA) vaccines and therapeutics, announces
Source: finanznachrichten.de
9 Meters Biopharma to Present at the American College of Gastroenterology 2022 Annual Scientific Meeting
RALEIGH, NC / ACCESSWIRE / October 18, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, announced
Source: finanznachrichten.de
Ashvattha Therapeutics Announces Preclinical Data on
– Data demonstrated [18F]OP-801 is a promising tracer for imaging activated macrophages/microglia with high sensitivity in the lumbar spine of a murine...
Source: globenewswire.com